TNO/ Holst Centre published whitepaper about integrating electronics in Organ-on-Chip
TNO/Holst Centre recently published a whitepaper about integrating electronics with Organ-on-Chip related technologies. Integration can assist in the development of better medicines, such as those for neurodegenerative and cardiovascular diseases.
Over the past decade, Organ-on-Chip (OoC) technology has become prominent in the world of drug development, with the first wave of OoCs already on the market. The second wave is expected to integrate electronics and sensors. With the integration of electronics, OoC-related technologies can assist in developing better medicines, such as those for neurodegenerative and cardiovascular diseases, with Brain and Heart-on-Chip devices.
Involvement of all stakeholders is essential to realize the full potential of OoC-related devices, to which TNO/Holst Centre looks to contribute its flexible electronics and manufacturing expertise.
This paper will touch on the industry's viewpoint, regarding the integration of electronics within in vitro devices, as well as the progress TNO/Holst Centre has made in creating solutions in this application domain.
Ref: Dustin D. Dopsa, Auke J. Kronemeijer and Gerwin Gelinck.(2020) TNO/Holst Centre, White papier: Integrating Electronics in Organ on Chip: can adoption be accelerated? (pdf)